Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 64,39 mln. 68,84 mln. | Omzet 2024 * | 73,53 mln. 78,62 mln. | Marktkapitalisatie | 63,14 mln. 67,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -39 mln. -41,7 mln. | Nettowinst (verlies) 2024 * | -26 mln. -27,8 mln. | EV/omzet 2023 | 1,51 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 0,86 x |
K/w-verhouding 2023 |
-2,37
x | K/w-verhouding 2024 * |
-2,46
x | Werknemers | 255 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 97,37% |
Recentste transcriptie over MDxHealth SA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |